Efficacy and safety of linagliptin in type 2 diabetes subjects at high risk for renal and cardiovascular disease: a pooled analysis of six phase III clinical trials

por von Eynatten, Maximilian, Gong, Yan, Emser, Angela, Woerle, Hans-Juergen
Publicado 2013

Blood glucose, diabetes and metabolic control in patients with community-acquired pneumonia

por Lepper, Philipp M., Bals, Robert, Jüni, Peter, von Eynatten, Maximilian
Publicado 2020

Effects of glycine and n-acetylcysteine on glutathione levels and mitochondrial energy metabolism in healthy aging

por Gut, Philipp, Lizzo, Giulia, Migliavacca, Eugenia, Karagounis, Leonidas, Heise, Tim, Eynatten, Maximilian
Publicado 2021

Effects of glycine and n-acetylcysteine on glutathione levels and mitochondrial energy metabolism in healthy aging

por Gut, Philipp, Lizzo, Giulia, Migliavacca, Eugenia, Karagounis, Leonidas, Heise, Tim, Eynatten, Maximilian
Publicado 2021

Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme

por Johansen, Odd Erik, Neubacher, Dietmar, von Eynatten, Maximilian, Patel, Sanjay, Woerle, Hans-Juergen
Publicado 2012

Empagliflozin Induces Transient Diuresis Without Changing Long-Term Overall Fluid Balance in Japanese Patients With Type 2 Diabetes

por Yasui, Atsutaka, Lee, Ganghyuck, Hirase, Tetsuaki, Kaneko, Tatsuroh, Kaspers, Stefan, von Eynatten, Maximilian, Okamura, Tomoo
Publicado 2018

Linagliptin Lowers Albuminuria on Top of Recommended Standard Treatment in Patients With Type 2 Diabetes and Renal Dysfunction

por Groop, Per-Henrik, Cooper, Mark E., Perkovic, Vlado, Emser, Angela, Woerle, Hans-Juergen, von Eynatten, Maximilian
Publicado 2013

Efficacy and safety of linagliptin in Hispanic/Latino patients with type 2 diabetes mellitus: a pooled analysis from six randomized placebo-controlled phase 3 trials

por Davidson, Jaime A, Lajara, Rosemarie, Aguilar, Richard B, Mattheus, Michaela, Woerle, Hans-Juergen, von Eynatten, Maximilian
Publicado 2014

Empagliflozin and kidney outcomes in Asian patients with type 2 diabetes and established cardiovascular disease: Results from the EMPA‐REG OUTCOME(®) trial

por Kadowaki, Takashi, Nangaku, Masaomi, Hantel, Stefan, Okamura, Tomoo, von Eynatten, Maximilian, Wanner, Christoph, Koitka‐Weber, Audrey
Publicado 2019

Long-Term Efficacy and Safety of Linagliptin in Patients With Type 2 Diabetes and Severe Renal Impairment: A 1-year, randomized, double-blind, placebo-controlled study

por McGill, Janet B., Sloan, Lance, Newman, Jennifer, Patel, Sanjay, Sauce, Christophe, von Eynatten, Maximilian, Woerle, Hans-Juergen
Publicado 2013

A randomised, active- and placebo-controlled, three-period crossover trial to investigate short-term effects of the dipeptidyl peptidase-4 inhibitor linagliptin on macro- and micro...

por Jax, Thomas, Stirban, Alin, Terjung, Arne, Esmaeili, Habib, Berk, Andreas, Thiemann, Sandra, Chilton, Robert, von Eynatten, Maximilian, Marx, Nikolaus
Publicado 2017

Linagliptin treatment is associated with altered cobalamin (VitB12) homeostasis in mice and humans

por Tammen, Harald, Kömhoff, Martin, Delić, Denis, Lund, Søren S., Hocher, Berthold, Frankenreiter, Sandra, Hess, Rüdiger, von Eynatten, Maximilian, Mark, Michael, Klein, Thomas
Publicado 2023

Acute Effect of Empagliflozin on Fractional Excretion of Sodium and eGFR in Youth With Type 2 Diabetes

por Bjornstad, Petter, Laffel, Lori, Tamborlane, William V., Simons, Gudrun, Hantel, Stefan, von Eynatten, Maximilian, George, Jyothis, Marquard, Jan, Cherney, David Z.I.
Publicado 2018

Associations of Fetuin-A levels with vascular disease in type 2 diabetes patients with early diabetic nephropathy

por Roos, Marcel, Oikonomou, Dimitrios, von Eynatten, Maximilian, Luppa, Peter B, Heemann, Uwe, Lutz, Jens, Baumann, Marcus, Nawroth, Peter P, Bierhaus, Angelika, Humpert, Per M
Publicado 2010

The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus

por Cherney, David ZI, Perkins, Bruce A, Soleymanlou, Nima, Har, Ronnie, Fagan, Nora, Johansen, Odd Erik, Woerle, Hans-Juergen, von Eynatten, Maximilian, Broedl, Uli C
Publicado 2014

Hemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin with renin–angiotensin system inhibitors in type 2 diabetic patients with albuminuria

por Cooper, Mark E., Perkovic, Vlado, Groop, Per-Henrik, Hocher, Berthold, Hehnke, Uwe, Meinicke, Thomas, Koitka-Weber, Audrey, van der Walt, Sandra, von Eynatten, Maximilian
Publicado 2019

Nephrotic-range proteinuria in type 2 diabetes: Effects of empagliflozin on kidney disease progression and clinical outcomes

por Ruggenenti, Piero, Kraus, Bettina J., Inzucchi, Silvio E., Zinman, Bernard, Hantel, Stefan, Mattheus, Michaela, von Eynatten, Maximilian, Remuzzi, Giuseppe, Koitka-Weber, Audrey, Wanner, Christoph
Publicado 2021

Oligomalt, a New Slowly Digestible Carbohydrate, Is Well Tolerated in Healthy Young Men and Women at Intakes Up to 180 Gram per Day: A Randomized, Double-Blind, Crossover Trial

por Johansen, Odd Erik, Curti, Delphine, von Eynatten, Maximilian, Rytz, Andreas, Lahiry, Anirban, Delodder, Frederik, Ufheil, Gerhard, D’Urzo, Carmine, Orengo, Audrey, Thorne, Kate, Lerea-Antes, Jaclyn S.
Publicado 2023

The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study

por Herrington, William G, Preiss, David, Haynes, Richard, von Eynatten, Maximilian, Staplin, Natalie, Hauske, Sibylle J, George, Jyothis T, Green, Jennifer B, Landray, Martin J, Baigent, Colin, Wanner, Christoph
Publicado 2018

The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study

por Herrington, William G, Preiss, David, Haynes, Richard, von Eynatten, Maximilian, Staplin, Natalie, Hauske, Sibylle J, George, Jyothis T, Green, Jennifer B, Landray, Martin J, Baigent, Colin, Wanner, Christoph
Publicado 2019